503B Docket

SCA Pharmaceuticals 503B outsourcing facility · Little Rock, AR

This is a record of what FDA published, not a rating. Last FDA inspection and Form 483 status below are as published in FDA's registered outsourcing facilities table (as of Sep 30, 2026).

FDA registration record

Listed by FDA asSCA Pharmaceuticals, Little Rock, AR
City / stateLittle Rock, AR
FDA's table lists city and state only, not a street address.
Contact phone (as listed by FDA)1-877-550-5059
Initial registration date12/13/2013
Most recent registration date12/5/2025
Outsourcing facilities must re-register annually (Oct 1 – Dec 31) to remain on FDA's list.
Last inspection (FDA table)10/30/2025
Form 483 issued at last inspection?Yes · View Form 483 (FDA PDF)
Recall conducted? (FDA table)No
Action based on last inspectionWarning Letter Issued 9/14/2026
“Open” means FDA has not determined whether further action will be taken (per FDA's table notes).
Intends to compound sterile drugs from bulk substancesYes
Self-reported by the facility at registration; FDA notes this information has not been verified by FDA.

Source: FDA Registered Outsourcing Facilities

Published FDA records

3Form 483 records
1Warning letters
13Recall events (openFDA)
0Uncertain-match items

Counts include only items from FDA's table or exact name + city + state matches. They are counts of published records, not a score. Uncertain matches are shown below but not counted.

State board of pharmacy license lookup

Arkansas State Board of Pharmacy (board site)

Search the state board's lookup for this facility's license status and any disciplinary actions. We link to the state-level tool only and do not list license numbers. FDA's table does not include state board actions. Facilities that ship across state lines may also hold non-resident licenses in your state, so check your own state's board too.

Verify directly

Represent this facility? Claim this profile. Claimed profiles never change FDA records.

Timeline of FDA actions

Newest first. Sources: FDA's registration table, FDA's compounding actions page (2019 onward on the live page), and openFDA drug enforcement records. Items marked Uncertain match may relate to a different site or entity and are not counted. How matching works.

  1. Warning letter FDA table
    Warning Letter Issued 9/14/2026
    No document link published · FDA registered outsourcing facilities table
  2. Firm response to Form 483 Matched
    483 Response Issued 11/21/2025 (PDF - 3.74MB)
    Listed on FDA page under: SCA Pharmaceuticals, LLC, Little Rock, AR - 503B Facility
    FDA document · FDA Compounding: Inspections, Recalls, and other Actions
  3. Inspection FDA table
    Last inspection per FDA table; Form 483 issued: Yes
    FDA document · FDA registered outsourcing facilities table
  4. Form FDA 483 FDA table
    Form FDA 483 (linked from FDA's registration table)
    FDA document · FDA registered outsourcing facilities table
  5. FMD-145 letter Matched
    FMD-145 Letter Issued 9/29/2023
    Listed on FDA page under: SCA Pharmaceuticals, LLC, Little Rock, AR - 503B Facility
    No document link published · FDA Compounding: Inspections, Recalls, and other Actions
  6. Form FDA 483 Matched
    483 Issued 05/17/2023 (PDF - 1 MB)
    Listed on FDA page under: SCA Pharmaceuticals, LLC, Little Rock, AR - 503B Facility
    FDA document · FDA Compounding: Inspections, Recalls, and other Actions
  7. FMD-145 letter Matched
    FMD-145 Letter Issued 08/19/2021
    Listed on FDA page under: SCA Pharmaceuticals, LLC, Little Rock, AR - 503B Facility
    No document link published · FDA Compounding: Inspections, Recalls, and other Actions
  8. Warning letter close-out Matched
    Warning Letter Close Out Issued 08/19/2021
    Listed on FDA page under: SCA Pharmaceuticals, LLC, Little Rock, AR - 503B Facility
    No document link published · FDA Compounding: Inspections, Recalls, and other Actions
  9. Recall Matched
    Recall event 86982
    Class II · Terminated · 1 product line(s) · Recall no. D-0171-2021
    Recalling firm as listed: SCA Pharmaceuticals, Inc., Little Rock, AR. Reason: Subpotent drug.
    openFDA record · openFDA drug enforcement API
  10. Form FDA 483 Matched
    483 Issued 11/07/2019 (PDF - 724 KB)
    Listed on FDA page under: SCA Pharmaceuticals, LLC, Little Rock, AR - 503B Facility
    FDA document · FDA Compounding: Inspections, Recalls, and other Actions
  11. Recall Matched
    Recall event 80915
    Class I · Terminated · 1 product line(s) · Recall no. D-1189-2018
    Recalling firm as listed: SCA Pharmaceuticals, Inc., Little Rock, AR. Reason: Presence of Precipitate: Customer complaint for visible precipitate in product believed to be the active ingredient furosemide.
    openFDA record · openFDA drug enforcement API
  12. Recall Matched
    Recall event 80425
    Class II · Terminated · 1 product line(s) · Recall no. D-0918-2018
    Recalling firm as listed: SCA Pharmaceuticals, Little Rock, AR. Reason: Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding.
    openFDA record · openFDA drug enforcement API
  13. Recall Matched
    Recall event 78708
    Class II · Terminated · 1 product line(s) · Recall no. D-0156-2018
    Recalling firm as listed: SCA Pharmaceuticals, Little Rock, AR. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date - product label was missing lot number and beyond use date.
    openFDA record · openFDA drug enforcement API
  14. Recall Matched
    Recall event 78320
    Class II · Terminated · 10 product line(s) · Recall no. D-0059-2018, D-0060-2018, D-0061-2018, D-0062-2018, D-0063-2018, D-0064-2018 …
    Recalling firm as listed: SCA Pharmaceuticals, LLC, Little Rock, AR. Reason: Lack Of Assurance Of Sterility.
    openFDA record · openFDA drug enforcement API
  15. Recall Matched
    Recall event 77770
    Class II · Terminated · 30 product line(s) · Recall no. D-1005-2017, D-1006-2017, D-1007-2017, D-1008-2017, D-1009-2017, D-1010-2017 …
    Recalling firm as listed: SCA Pharmaceuticals, Little Rock, AR. Reason: Lack of Assurance of Sterility; product has the potential to leak.
    openFDA record · openFDA drug enforcement API
  16. Recall Matched
    Recall event 77777
    Class II · Terminated · 6 product line(s) · Recall no. D-0999-2017, D-1000-2017, D-1001-2017, D-1002-2017, D-1003-2017, D-1004-2017
    Recalling firm as listed: SCA Pharmaceuticals, Little Rock, AR. Reason: Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.
    openFDA record · openFDA drug enforcement API
  17. Recall Matched
    Recall event 77600
    Class II · Terminated · 4 product line(s) · Recall no. D-0976-2017, D-0977-2017, D-0978-2017, D-0979-2017
    Recalling firm as listed: SCA Pharmaceuticals, Little Rock, AR. Reason: Lack of sterility assurance
    openFDA record · openFDA drug enforcement API
  18. Recall Matched
    Recall event 77314
    Class II · Terminated · 10 product line(s) · Recall no. D-0870-2017, D-0871-2017, D-0872-2017, D-0873-2017, D-0874-2017, D-0875-2017 …
    Recalling firm as listed: SCA Pharmaceuticals, Little Rock, AR. Reason: Lack of assurance of sterility: Product bags leaking at seam.
    openFDA record · openFDA drug enforcement API
  19. Recall Matched
    Recall event 76395
    Class I · Terminated · 7 product line(s) · Recall no. D-0639-2017, D-0640-2017, D-0641-2017, D-0642-2017, D-0643-2017, D-0644-2017 …
    Recalling firm as listed: SCA Pharmaceuticals, Little Rock, AR. Reason: Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.
    openFDA record · openFDA drug enforcement API
  20. Recall Matched
    Recall event 71166
    Class II · Terminated · 1 product line(s) · Recall no. D-1133-2015
    Recalling firm as listed: SCA Pharmaceuticals, Little Rock, AR. Reason: Labeling: Label Mix-Up: Product is incorrectly labeled as phenylephrine 50 mg in 0.9% sodium chloride rather than phenylephrine 50 mg in 5% dextrose.
    openFDA record · openFDA drug enforcement API
  21. Recall Matched
    Recall event 70583
    Class II · Terminated · 1 product line(s) · Recall no. D-0965-2015
    Recalling firm as listed: SCA Pharmaceuticals, Little Rock, AR. Reason: Presence of particulate.
    openFDA record · openFDA drug enforcement API
  22. Recall Matched
    Recall event 70167
    Class II · Terminated · 1 product line(s) · Recall no. D-0339-2015
    Recalling firm as listed: SCA Pharmaceuticals, Little Rock, AR. Reason: Labeling: Incorrect or missing Lot and/or Exp Date: Printing error caused an overlap in the "y" and "3" making the actual "Use By 3/2015" date appear to read "Use By8/2015".
    openFDA record · openFDA drug enforcement API